BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 20 filers reported holding BELLEROPHON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13 | -43.5% | 33 | 0.0% | 0.00% | – |
| Q2 2023 | $23 | -100.0% | 33 | -100.0% | 0.00% | -100.0% |
| Q1 2023 | $7,112,574 | +534680.0% | 901,467 | +60933.6% | 0.00% | – |
| Q4 2022 | $1,330 | -33.5% | 1,477 | +0.5% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 1,470 | -0.2% | 0.00% | – |
| Q2 2022 | $2,000 | -60.0% | 1,473 | -32.9% | 0.00% | – |
| Q1 2022 | $5,000 | -70.6% | 2,195 | -60.0% | 0.00% | – |
| Q4 2021 | $17,000 | +142.9% | 5,487 | +201.0% | 0.00% | – |
| Q3 2021 | $7,000 | -22.2% | 1,823 | -10.5% | 0.00% | – |
| Q2 2021 | $9,000 | +800.0% | 2,038 | +972.6% | 0.00% | – |
| Q1 2021 | $1,000 | -97.1% | 190 | -96.4% | 0.00% | – |
| Q4 2020 | $34,000 | +36.0% | 5,225 | +115.2% | 0.00% | – |
| Q3 2020 | $25,000 | -35.9% | 2,428 | -21.6% | 0.00% | – |
| Q2 2020 | $39,000 | +34.5% | 3,098 | +17.7% | 0.00% | – |
| Q1 2020 | $29,000 | – | 2,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 69,000 | $85,000 | 0.10% |
| Sepio Capital, LP | 23,800 | $29,000 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 20,000 | $25,000 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 500 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,000 | $1,000 | 0.00% |
| US BANCORP \DE\ | 1,221 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 200,057 | $246,000 | 0.00% |
| NORTHERN TRUST CORP | 28,097 | $35,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 64,355 | $79,000 | 0.00% |